With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...
Welltica+ on MSN
Diabetes medication may reduce risk of eye disease by 37 percent
A common medication may have an unexpected effect on a serious eye condition, new research suggests.
Dry eye disease (DED) is one of the most common ocular surface disorders. All DED involves an imbalance between tear production and evaporation. Most cases of DED are driven by excessive evaporation, ...
Zacks Investment Research on MSN
ALDX crashes 71% as FDA issues third CRL for dry eye disease drug NDA
Shares of Aldeyra Therapeutics ALDX plunged 70.7% on Tuesday after the company announced receiving a Complete Response Letter ...
FRESNO, Calif. (KFSN) -- A Fresno eye doctor is the first in the Valley to offer a groundbreaking light-based treatment for dry eye disease. According to doctors, dry eye disease is a common condition ...
Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD; explore the current treatment landscape of dry eye disease. This is a video synopsis/summary of a Stakeholder Summit involving: Ryan Haumschild, ...
Please provide your email address to receive an email when new articles are posted on . Thyroid eye disease treatments have evolved significantly in recent years. Work is still needed to find durable, ...
Researchers have successfully used a new robot system to improve treatment for debilitating eye disease. Researchers from King's, with doctors at King's College Hospital NHS Foundation Trust, have ...
More than 360 million people around the world suffer from dry eye disease, which is characterized by chronically red, scratchy or irritated eyes. blackday - stock.adobe.com Dry eye disease is no ...
After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...
Fluctuating vision is the most frequently cited complaint, exceeding classic discomfort symptoms, and may divert patients toward refractive explanations before DED is recognized and treated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results